Slu-Pp-332-(1000mcg-X-30-Capsules-=-30,000mcg)
$200.00
SLU-PP-332 is an experimental compound designed to mimic the metabolic effects of exercise by activating estrogen-related receptors (ERRs), particularly ERRĪ±, ERRĪ², and ERRĪ³. This activation leads to increased energy expenditure, enhanced fatty acid oxidation, and improved mitochondrial function.
Published Research:
-
Metabolic Benefits in Obese Mice:Ā A study published in theĀ Journal of Pharmacology and Experimental TherapeuticsĀ demonstrated that SLU-PP-332 administration in diet-induced obese or genetically obese (ob/ob) mice resulted in increased energy expenditure and fatty acid oxidation. These metabolic changes were accompanied by decreased fat mass accumulation, suggesting potential therapeutic applications for metabolic disorders. SLU-PP-332 has been shown to promote weight loss and reduce fat accumulation in obese mice without affecting food intake or requiring increased physical activity.
-
Enhanced Exercise Endurance:Ā Research reported inĀ ACS Chemical BiologyĀ found that SLU-PP-332 increased the proportion of oxidative muscle fibers in mice, leading to enhanced exercise endurance. This effect was attributed to improved mitochondrial function and cellular respiration in skeletal muscle cells.
-
Potential Treatment for Heart Failure:Ā Studies presented by the American Chemical Society indicated that SLU-PP-332 improved cardiac function in mouse models of heart failure. The compound enhanced mitochondrial ultrastructure and upregulated pathways associated with oxidative phosphorylation and fatty acid metabolism, suggesting its potential as a therapeutic agent for heart failure.
While these findings are promising, it’s important to note that SLU-PP-332 is still in the preclinical stage of development. Further research, including human clinical trials, is necessary to fully understand its efficacy and safety profile.
Related products
